We build breakthrough biotech companies with. Meet the people behind our portfolio. Great science, great companies.

Some thoughts from a scientist who moved to the business side of biotech. Back in March, the NY Times. The article was inspired by a paper. Going even further than that, Peter Bach, one of the authors of the paper, infers that drug companies are intentionally.

Lab conflict and how to address it. Conflict is a fact of life. Scientists should find ways to manage it in the lab, says Benjamin Tsang. The closing date is 5 April 2018.

Perspectives on lab-on-a-chip, microfluidic, and bioMEMS technology. Flow control survey by the MFmanufacturing project. Just received the following request from Henne van Heeren of EnablingMNT who is doing a survey on microfluidic flow control. Your information will be coded and will remain confidential.

Some thoughts straight from the heart. Sunday, May 31, 2015. Entrepreneurs have always propelled this economy. It all begins with the drive to create change. The unique breed of people ride the roller-coaster of building a business and have fun doing it. The inspiration for the this post is from a talk I heard at TiE Boston by Nitin Nohria. We always hear cash is king. For entrepreneurs this translates to why sales is king.

Startups, Life Science, and Personal Development. This is a post of the startup musings series. You can read all the posts in this series here. Last time I posted two commentaries, one on a bioentrepreneur article. And another on a Inc. I claimed they are somehow connected. So what exactly is the connection between these two pieces? Or is one school of thought simply wrong? If so, why? What you need is an A team! The t.

Stuff about building life science companies in Louisville, KY. But, listed below are several reported amounts.